| P | roducts - NEW PRODUCTS |
Sr
Product
Therapeutic Use
Regulatory Status
1
Hydrochlorothiazide
Diuretic
DMF - February 2012
2
Telmisartan
Anti-hypertensive
DMF - March 2012
3
Irbesartan
Anti-hypertensive
DMF - July 2012
4
Valsartan
Anti-hypertensive
DMF - September 2012
5
Rosuvastatin
Anti-hyperlipidemic
DMF - October 2012
6
Aripiprazole<
Anti-depressant/
Anti-psychotic
Anti-psychotic
DMF - November 2012
7
Linezolid
Antibiotic
DMF - November 2012
8
Olmesartan
Anti-hypertensive
DMF - December 2012
9
Chlorthalidone
Diuretic
DMF - January 2013
10
Sitagliptin
Anti-diabetic
DMF - April 2013
11
Pregabalin
Anti-convulsant
DMF - June 2013
12
Bosentan
Pulmonary Arterial Hypertension
DMF - July 2013
Note : All Transactions are carried out in conformity with the patent laws applicable in the user country. Responsibility with respect to third party’s patent rights in a specific country lies exclusively with the buyer.
API PLANTS :
1. VAPI, GUJRAT – USFDA & EU-GMP APPROVED
2. BARODA, GUJRAT – USFDA APPROVED
API PLANTS :
1. VAPI, GUJRAT – USFDA & EU-GMP APPROVED
2. BARODA, GUJRAT – USFDA APPROVED
About us | API | Intermediates | Products Under Development | Contract Research | Custom Synthesis | Global Presence | Our Facilities | Quality | R & D
Careers | Contact us | Sitemap
©Amoli Organics Pvt. Ltd. 2010. Powered by Cyber Impression